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Health care-associated infections (HAIs) are a burden to patients and the health care system. It is estimated that up to 50% of HAIs are preventable. 1, 2 In 2002, however, HAIs in US hospitals reportedly reached ∼1.7 million, with >33 000 HAIs among infants in high-risk nurseries. 3 Central line-associated bloodstream infections (CLABSIs) have the highest cost per HAI and contribute to significant morbidities, mortality, and length of stay in the adult, pediatric, and neonatal populations. [4] [5] [6] The overall direct annual cost of US HAIs ranges from $35.7 to $45 billion for inpatient hospital services. 7 Although the actual cost of CLABSIs varies, the attributable cost to care is up to $69 000 per event. [7] [8] [9] [10] [11] Despite the risks with their use, central venous catheters (CVCs) play an integral role in modern health care. 12 The need for CVCs is particularly important in children's hospital NICUs for patients who abstract OBJECTIVE: Reduce central line-associated bloodstream infection (CLABSI) rates 15% over 12 months in children's hospital NICUs. Use orchestrated testing as an approach to identify important CLABSI prevention practices.
METHODS:
Literature review, expert opinion, and benchmarking were used to develop clinical practice recommendations for central line care. Four existing CLABSI prevention strategies (tubing change technique, hub care monitoring, central venous catheter access limitation, and central venous catheter removal monitoring) were identified for study. We compared the change in CLABSI rates from baseline throughout the study period in 17 participating centers. Using orchestrated testing, centers were then placed into 1 of 8 test groups to identify which prevention practices had the greatest impact on CLABSI reduction.
RESULTS:
CLABSI rates decreased by 19.28% from 1.333 to 1.076 per 1000 line-days. Six of the 8 test groups and 14 of the 17 centers had decreased infection rates; 16 of the 17 centers achieved >75% compliance with process measures. Hub scrub compliance monitoring, when used in combination with sterile tubing change, decreased CLABSI rates by 1.25 per 1000 line-days.
CONCLUSIONS:
This multicenter improvement collaborative achieved a decrease in CLABSI rates. Orchestrated testing identified infection prevention practices that contribute to reductions in infection rates. Sterile tubing change in combination with hub scrub compliance monitoring should be considered in CLABSI reduction efforts.
have diagnoses associated with impaired cardiorespiratory and intestinal function. 13 CVCs are necessary for fluids, nutrition, and medications. Although not CLABSIspecific, evidence is growing that patients with a neonatal infection are more likely to have long-term neurodevelopmental impairment and lower scores on motor and psychosocial development indices. 14 The processes to lower CLABSI rates could therefore have a powerful impact on NICU outcomes.
Centers participating in the Children's Hospitals Neonatal Database (CHND), a data repository developed for IIIc 15 NICUs, established the CHND Collaborative Initiatives for Quality Improvement (CIQI) in 2009 to lead quality improvement (QI) projects in children's hospital NICUs. CHND currently has 28 member tertiary and quaternary NICUs. 13 Clancy et al 16 as well as others 17 have recently described a need for this type of formal structure for collaborative QI projects. The purpose of the SLUG Bug (Standardizing Line Care Under Guideline Recommendations) collaborative was to provide potentially better practice recommendations for neonatal health care professionals in care and maintenance of CVCs and to prevent CLABSIs. The 12-month baseline mean CLABSI rate for the collaborative was 1.33 per 1000 line-days (center-specific rates varied from 0.23 to 3.4), which is below the rate of 1.55 per 1000 line-days reported by the National Healthcare Safety Network's Level III NICUs in 2011. 18 The SMART (Specific, Measurable, Attainable, Relevant, Timeframe) aim of SLUG Bug was to decrease collaborative baseline CLABSI rates by a clinically meaningful target of 15% over 12 months. A second objective of this project was to use orchestrated testing (OT) to identify important CLABSI prevention practices. 25, 26 The primary outcome measure was CLABSI rates according to the National Healthcare Safety Network's definition of CLABSI. 27 Process measures were defined and collected by self-report or direct observation (Table 4) . For the groups assigned to compliance monitoring, a minimum of 10 observations per month from a consistent observer were required as described in the Clinical Practice Recommendation, with an expected target compliance of >75% and an ideal target of ≥90%. Each local team instituted tools and processes for data collection and shared information among sites to adapt as needed. The balancing measure was defined as unintended line replacement.
METHODS

SLUG
Baseline CLABSI rates were established on the basis of rates at each site from January 2011 to December 2011. The study period (January 2012-December 2012) focused on compliance monitoring, data sharing, and ongoing local Plan-Do-Study-Act cycles to achieve targeted improvement goals. Centers were expected to submit outcome and process measure compliance data monthly.
Monthly CLABSI rates ([CLABSI events divided by central linedays] × 1000) for each center were analyzed as time series outcome variables by using Statistical Process Control charts (Shewhart u charts). 28 Rational subgrouping was used to study both variation over time and variation between NICUs and test groups. Signals, indicating special cause, were identified by using standard control chart rules. After detecting special cause signals that supported a significant change, the limits for the u chart were calculated for both the baseline and study periods, and signals that indicated a change in the time series were identified. by guest on October 10, 2018 www.aappublications.org/news Downloaded from Power was calculated by using a historical CLABSI rate from a sampling of CHND centers. Preliminary calculations found a baseline rate of 1.1 per 1000 linedays; however, once data from all of the participating centers were available, the actual baseline rate was later determined to be 1.33 per 1000 line-days. Average monthly line-days needed for each test group were estimated to be 1000, yielding an SE for each test group of 1.05. Thus, the SE of the difference in factor levels was 0.742. A baseline and study period of 6 months would allow the detection of a change in CLABSI rate >0.3 (under ideal experimental conditions). To achieve this power, a minimum replication of 6000 linedays per test group was required over the study period. Study-It software (McGraw-Hill Professional, New York, NY) was used to estimate and analyze each of the 4 factors' effect and their interactions and to create the appropriate response plots. 22 Main effect terms for each of the factors in the study were evaluated. This analytical approach assumes that the effects of all factors and interaction pairs can be evaluated. Correlation analysis with scatter plots was used to assess for any association between compliance and CLABSIs. This methodology does not involve confidence intervals or P values but does use statistical process control charts and repetition to verify the results.
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RESULTS
The collaborative CLABSI rate decreased from a baseline rate of 1.333 to 1.076 per 1000 linedays, a 19.28% reduction. During the baseline period, there was no special cause signal that indicated random variation in rates across the participating sites from January 2011 to August 2011. However, after 8 months, the collaborative CLABSI rates showed a special cause signal on the u chart. After this signal, a new center-line was determined and was sustained for the remaining 4 months (Fig 1) . A total of 235 990 line-days (116 987 in the baseline period and 119 003 in the study period) were analyzed. Three single-center groups (1, 2, and 4) consistently had <1000 line-days per month; group 6 had 8 months of <1000 line-days and group 7 had 3 months of <1000 line-days; and groups 3, 5, and 8 had >1000
line-days each month throughout the study period.
Fourteen of the 17 centers had a decrease in rates during the study period (Table 3) No unit policy to assess CVC daily need and utilization
The factors are outlined with their dichotomous defi nition for this project. Centers followed these defi nitions for reporting according to their OT matrix assignment. This design matrix shows dichotomous factors with group and hospital assignments. The baseline period was January 2011 through December 2011, and the study period was January 2012 through December 2012. CLABSI rates are defi ned per 1000 line-days. Hospital G was removed because of nonadherence to assignment, and hospital M withdrew from the project.
an average decrease in CLABSI rates of 1.25 per 1000 line-days (Fig 2) . Figure 3 displays the consistency and variation of the TC change and HC effects shown in Fig 2. Three of the 4 test groups using sterile TC demonstrated a decrease in CLABSI rates (Table 3 , Fig 3) . Group 2 (a single-center group) that performed both HC monitoring and sterile TC techniques demonstrated the greatest decrease. Three of the 4 groups using clean TC (5 centers; groups 1, 3, and 7) had baseline CLABSI rates below the collaborative mean and maintained low rates. Group 5, comprising 3 centers using clean TC, had a baseline mean of 1.39 and an increase in CLABSI rates at the completion of the study.
Most centers reported compliance by using a combination of self-reporting or direct observation. There was no association between compliance and CLABSI rates. Sixteen centers achieved >75% compliance, and 12 of these centers reached >90% compliance. HC compliance ranged from 92% to 100%, whereas TC technique compliance ranged from 82% to 100%. The CVC device utilization ratio did not change over time. Four teams reporting on the balancing measure (2 with specific monitoring for CVC removal and 2 without such monitoring) showed no change in need for line replacement. Using the IHI assessment score 25 as a measure of local team success, 11 of 17 centers achieved scores ≥3.5 (moderate achievement), and 6 of 17 achieved scores ≥4 (significant improvement).
DISCUSSION
The present QI project had 2 objectives: (1) to reduce CLABSI rates by 15% over 12 months; and (2) to identify potential best practices for CLABSI prevention. With regard to the first objective, all participating centers had active CLABSI prevention policies at the onset of the project and most had CLABSI rates lower than the national average. Nevertheless, we reported a collaborative reduction in CLABSI rates from baseline by nearly 20% in the first 8 months of the study period. Second, utilizing OT as a study design, this collaborative is the first to be able to identify specific factors that may further impact NICU CLABSI reductions. Number of lines that were reinserted within 48 h after CVC removal because they were determined not to be medically needed/total number of lines Four of the listed process measures were study factors in accordance with the matrix assignment. a Hand hygiene was reported as a background variable throughout the study period.
FIGURE 1
SLUG Bug CLABSI rates from extended baseline throughout the study period for 17 participating centers. The u chart displays a decrease in CLABSI rates, from 1.333 to 1.076 per 1000 line-days. Statistical Process Control special-cause signaling (8 consecutive points below the mean). There was no further signaling for the duration of the study period. The overall reduction was 19.28%. LCL, lower control limit; UCL, upper control limit.
by guest on October 10, 2018 www.aappublications.org/news Downloaded from decreased mean adult ICU CLABSI rates from 7.7 to 1.4. Miller et al 35 reported that the main driver for additional reduction of CLABSI rates in a PICU compared with an adult ICU was the daily maintenance care bundle. As with many of these studies, we incorporated evidencebased guidelines and literature. We also enlisted expert opinion and used the CHND network to benchmark best practices for prevention of CLABSIs.
QI collaboratives have variable results in demonstrating improvement, cost-effectiveness, and sustainability. 34, 36, 37 Although Wirtschafter et al 29 reported a decrease in CLABSI rates in a statewide QI-based study, they were unable to indicate which elements of the intervention were responsible for rate changes. Through the use of OT, we were able to evaluate specific CLABSI reduction practices over a relatively short period of time to identify which factors had the greatest effect. 28, [38] [39] [40] Using OT, we found that of the 4 factors studied, sterile TC had an effect in decreasing CLABSI rates. The combination of sterile TC with HC compliance monitoring had the greatest effect. Our results suggest that if a NICU implements sterile TC practices, CLABSI rates should decrease by 0.51 per 1000 line-days. If this same NICU added HC compliance monitoring, the impact would then be larger, lowering rates by 1.25 per 1000 line-days. Sterile TC has not been considered a primary CLABSI prevention factor but rather has been recommended in conjunction with other interventions in standard CLABSI prevention bundles. 21 We suspect this combination of practices reflect a culture of heightened vigilance for line care.
There are limitations to the SLUG Bug project. CLABSI prevention is complex, and additional practices (beyond the scope of our project) may contribute to a low CLABSI rate. Several centers using clean TC had low CLABSI rates throughout the collaborative. These centers may have established practices, individual or in combination, that are important but were not monitored. Lastly, there was unequal distribution of centers and central line-days across groups. Due to this variability, the estimate of the magnitude of the effect was not as accurate as initially planned. However, one of the strengths of OT is that the analysis is based on group outcome rather than center outcome and, with sufficient replication (ie, central line-days across sites), it provides the strength to define the generalizable impact of the study factors.
Forgoing randomization may be considered a weakness, resulting in a biased estimation of factor effects and unequal line-day distribution. OT, as an application of planned experimentation without center randomization, uses graphical methods with repeated samples to identify improvement in real time over a wide range of conditions. 22, 23 In addition, we did not capture the change in practice among centers as they entered the project. Some centers maintained their current central line care while others instituted a change in practice. It is through replication in future systems that the benefits of the OT results will be confirmed. This analytic approach to QI is a relatively new concept. We believe this method strengthens the project because it represents realworld dynamics and may lead to greater commitment as local teams (or centers) focus on areas of specific importance to their systems. As such, these results are more generalizable to clinical practice.
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FIGURE 2
A, Interaction plot between TC and monitoring HC. B, Response plot for TC alone. There are challenges in QI implementation across participating centers that may have competing commitments for time and personnel. 30 Despite the initial assignments, 1 center was moved to a different group to reconcile the clinical practice with the group factor assignment; 1 center never submitted data and was removed from all analytics; and the data from 1 center were retained for overall analysis but removed from the OT analysis because their practice did not coincide with the matrix group assignment.
This cohort included a complex patient population across institutions. The CLABSI Clinical Practice Recommendation is generalizable to other settings in which prolonged CVC use is medically necessary. Replication of these findings is important to confirm validity of the results. 22 Ongoing analysis will evaluate sustainability of these results. In addition, centers that transition to sterile TC can be followed to validate the impact of this practice. Decreasing the CLABSI rate offers benefits to patients, hospitals, and society. A decrease in the CLABSI rate by nearly 20% from a baseline rate of 1.333 would prevent ∼35 CLABSIs and save as many as 7 lives. 41 Based on published estimates of up to $69 000 attributable-cost per CLABSI, we could expect a cost-saving of up to $2.4 million. 6-11
CONCLUSIONS
The CHND CIQI national project, SLUG Bug, demonstrated a decrease in CLABSI rates. OT methods allowed learning from practice variation across centers. This approach to future collaborative QI projects is feasible and effective. The study framework accommodated sitespecific differences and identified practices that affect outcome. Our results support strong consideration for the use of sterile TC in conjunction with HC compliance monitoring to further reduce NICU rates of CLABSI.
health care professionals for the care and maintenance of central lines to prevent CLABSIs in infants in the NICU. Prevention of CLABSIs in the NICU will result in a decrease in both the morbidity and mortality associated with medical conditions that require care in the NICU, as well as an associated decrease in health care costs.
Hand Hygiene
The definition of hand hygiene (for staff and families) includes hand washing or use of hand sanitizer immediately before and after patient contact. [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] Hand Hygiene Technique
Alcohol Based
When decontaminating hands with an alcohol-based hand rub, apply product to the palm of 1 hand and rub hands together, covering all surfaces of hands and fingers, until hands are dry. Follow the manufacturer's recommendations regarding the volume of product to use.
Soap and Water
When washing hands with soap and water, wet hands first with water, apply an amount of product recommended by the manufacturer to hands, and rub hands together vigorously for at least 15 seconds, covering all surfaces of the hands and fingers. Rinse hands with water and dry thoroughly with a disposable towel. Use towel to turn off the faucet. 
Hand Hygiene Compliance
CENTRAL LINE INSERTION BUNDLE
CVC: A vascular infusion device that terminates at or close to the heart or in 1 of the great vessels. 51, 52 The following are considered great vessels for the purpose of reporting central line infections and counting central line-days in the National Healthcare Safety Network system: aorta, pulmonary artery, superior vena cava, inferior vena cava, brachiocephalic veins, internal jugular veins, subclavian veins, umbilical vessels, external iliac veins, and common femoral veins.
Central Line Insertion
Dedicated teams to place lines might be beneficial for promoting education and consistency of the insertion process. Team members may include trained registered nurses, neonatologists, neonatal nurse practitioners, surgeons, and interventional radiology physicians. 48 
